Cargando…

Renal Complication and Glycemic Control in Korean Veterans with Type 2 Diabetes: A 10-Year Retrospective Cohort Study

OBJECTIVE: Tight glycemic control reduces the risk of diabetes complications, but it may increase the risk of hypoglycemia or mortality in elderly patients. This study is aimed at evaluating the incidence and progression of renal complications and its association with glycemic control in elderly pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ye An, Lee, Young, Seo, Je Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333055/
https://www.ncbi.nlm.nih.gov/pubmed/32685562
http://dx.doi.org/10.1155/2020/9806790
Descripción
Sumario:OBJECTIVE: Tight glycemic control reduces the risk of diabetes complications, but it may increase the risk of hypoglycemia or mortality in elderly patients. This study is aimed at evaluating the incidence and progression of renal complications and its association with glycemic control in elderly patients with type 2 diabetes. METHODS: This retrospective cohort study examined the data of 3099 patients with type 2 diabetes who were followed for at least 10 years at the Korean Veterans Hospital and for whom glycated hemoglobin (HbA(1c)) was measured in 2008 and 2017. Participants were divided into six groups according to their baseline or dynamic HbA(1c) levels. Extended Cox models were used to calculate adjusted hazard ratios for the development of chronic kidney disease (CKD) and end-stage renal disease (ESRD) associated with specific HbA(1c) ranges. RESULTS: During the 10-year follow-up period, 30% of patients developed new CKD, 50% showed progression, and ESRD developed in 1.7%. The risk of CKD was associated with baseline HbA(1c) from the first year of the study and dynamic HbA(1c) throughout the study period. The adjusted hazard ratios for CKD were 1.98 and 2.32 for baseline and dynamic HbA(1c), respectively, at the level of ≥69 mmol/mol. There was no increased risk for any complications in baseline and dynamic HbA(1c) below 58 mmol/mol. CONCLUSIONS: A higher HbA(1c) ≥ 58 mmol/mol was associated with an increased risk of diabetes complications. A less stringent glycemic target of HbA(1c) could be used as the threshold of renal complications.